Cellumen, Inc. and Mitsubishi Tanabe Pharma Corporation Collaborate in Discovery Toxicology
PITTSBURGH--(BUSINESS WIRE)--Cellumen, Inc., a discovery toxicology company, today announced an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC), one of the leading pharmaceutical companies in Japan, to develop panels of biomarkers that identify toxicity early in the drug development process.